Text of NAM March-in Comments in California Stem Cell Study

May 21, 2021

∙ Paid

Here is the text of the section of the National Academy of Medicine’s 2012 study dealing with march-in rights at CIRM.

MARCH-IN RIGHTS

CIRM holds march-in rights that allow it to enter into license agreements on behalf of a grantee or its exclusive licensee with respect to a CIRM-funded invention under three circumstances: (1) the grantee, collaborator,…

Keep reading with a 7-day free trial

Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.